Sabby Healthcare Master Fund, Ltd. just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13G. In the filing, it appears as though Sabby Healthcare Master Fund, Ltd. claims to own 844,192 shares. This represents 4.82% of Biocept.
Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!
Other recent filings from the company include the following:
On February - Feb. 12, 2018
Sabby Healthcare Master Fund, Ltd. just issued a filing suggesting it has sold all of its Biocept - Feb. 1, 2018
On January - Jan. 30, 2018
Biocept just filed a prospectus, suggesting it plans to soon issue some securities - Jan. 26, 2018
Registration adding securities to prior Form S-1 registration [Rule 462(b)] - Jan. 26, 2018